Many men, especially those in demanding jobs or living in fast-paced environments, tend to overlook the importance of ...

Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

White button mushrooms promoted antitumor activity among men with prostate cancer, according to results of an ongoing randomized phase 2 trial.Treatment with white button mushroom tablets reduced ...

OncoAssure Ltd, an Irish medical diagnostic company, today announced the publication of new data, in the British Journal of Urology International Compass (BJUI Compass), which demonstrates the ...

For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk ...

In 2023 alone, 288,300 new cases of prostate cancer will be diagnosed in the United States, according to the American Cancer ...

High intensity focused ultrasound (HIFU) is a novel prostate cancer treatment that minimizes side effect while destroying ...

OncoAssure Ltd, an Irish medical diagnostic company, announced the publication of new data in the journal BJUI Compass that ...

A Bermudian genome researching organisation helped to unveil a project designed to pinpoint the genetic factors that make ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

More than 2 million new cases of cancer will be diagnosed in the US this year, and more than 600,000 people will die of cancer, researchers project.

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...